Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05689268

EUS-PPG vs HVPG in Portal Hypertension

Conditions: Cirrhosis, Portal Hypertension

Sex: All

Ages: 18 Years – 100 Years

Phase: NA

Enrollment: 53

Sponsor: Hospital General Universitario de Alicante

Location: Spain

Summary

The objective of this study is to evaluate the correlation of the calculated portal pressure gradient (PPG) obtained by direct portal and hepatic pressure measurements with a conventional 22 G needle guided by EUS and indirect portal vein pressure measurements using the interventional radiology based hepatic venous pressure gradient (HVPG) procedure.

Eligibility Criteria

Inclusion Criteria:Age above 18 yearsUndergoing evaluation for chronic liver disease or portal hypertensionSigned informed consentExclusion Criteria:Uncorrectable coagulopathy (INR above 1.5)Uncorrectable thrombocytopenia (Platelets under 50,000)Anticoagulation or antiplatelet therapy that cannot be discontinuedBiliary obstructionGrade II ascites or moreIntrahepatic portal vein thrombosisPregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05689268). StuddyBuddy aggregates publicly available trial information.